Effect of anthrax toxin's lethal factor on ion channels formed by the protective antigen.

The Journal of Biological Chemistry
J ZhaoR John Collier

Abstract

Protective antigen (PA), a component of anthrax toxin, mediates translocation of the toxin's lethal and edema factors (LF and EF, respectively) to the cytoplasm, via a pathway involving their release from an acidic intracellular compartment. PA63, a 63-kDa proteolytic fragment of PA, can be induced to form ionconductive channels in the plasma membrane of mammalian cells by acidification of the medium. These channels are believed to be comprised of dodecyl sulfate-resistant oligomers (heptameric rings) of PA63 seen by electron microscopy of the purified protein. Here we report that the PA63-mediated efflux of 86Rb+ from preloaded CHO-K1 cells under acidic conditions is strongly inhibited (> or = 70%) by LF or LFN, a PA-binding fragment of LF. Control proteins caused no inhibition. Evidence is presented that the inhibition involves partial blockage of ion conductance by the PA63 channel. Also, oligomer formation is slowed somewhat by LF at pH values near the pH threshold of channel formation (pH approximately 5.3), suggesting that channel formation may also be retarded under these conditions. The relevance of these results to the location of the LF-binding site on PA63 and the mechanism of LF and EF translocation is discussed.

References

Jan 1, 1977·Annual Review of Biochemistry·A M Pappenheimer
Nov 1, 1992·Proceedings of the National Academy of Sciences of the United States of America·K R KlimpelS H Leppla
Jun 1, 1991·Trends in Biochemical Sciences·D M Ojcius, J D Young
May 20, 1986·Biochemistry·J J Donovan, J L Middlebrook
Apr 1, 1989·Proceedings of the National Academy of Sciences of the United States of America·R O BlausteinA Finkelstein
Jan 1, 1986·Annual Review of Pharmacology and Toxicology·L L Simpson
Mar 1, 1985·Proceedings of the National Academy of Sciences of the United States of America·D H HochL L Simpson
Aug 1, 1981·Proceedings of the National Academy of Sciences of the United States of America·B L KaganM Colombini
May 1, 1982·Proceedings of the National Academy of Sciences of the United States of America·S H Leppla
Dec 1, 1982·Proceedings of the National Academy of Sciences of the United States of America·P Boquet, E Duflot
Sep 1, 1984·Microbiological Reviews·J L Middlebrook, R B Dorland
Jul 7, 1995·Annals of the New York Academy of Sciences·M YassaiJ Gorski
Nov 1, 1993·Proceedings of the National Academy of Sciences of the United States of America·P C HannaR J Collier

❮ Previous
Next ❯

Citations

Mar 11, 1998·International Journal of Biological Macromolecules·V CabiauxJ M Ruysschaert
Jul 9, 1999·Biochimica Et Biophysica Acta·W I LencerR K Holmes
Dec 14, 1999·Microbes and Infection·S F Little, B E Ivins
Sep 16, 2004·Nature Reviews. Molecular Cell Biology·Peter J M Van Haastert, Peter N Devreotes
Aug 6, 1996·Proceedings of the National Academy of Sciences of the United States of America·A P Pugsley
Jan 5, 2008·Photochemistry and Photobiology·Cara L BenjaminHonnavara N Ananthaswamy
Sep 9, 2004·Microbiology and Molecular Biology Reviews : MMBR·Holger BarthBradley G Stiles
Oct 23, 2003·Annual Review of Cell and Developmental Biology·R John Collier, John A T Young
Oct 28, 2005·Proceedings of the National Academy of Sciences of the United States of America·D Borden LacyR John Collier
May 2, 2003·Proceedings of the National Academy of Sciences of the United States of America·Jeanette I WebsterEsther M Sternberg
Nov 19, 2004·Proceedings of the National Academy of Sciences of the United States of America·Sen ZhangR John Collier
Jul 27, 2007·Critical Reviews in Microbiology·Ronald N KostoffSerkan Oncu
Apr 1, 1997·Molecular Membrane Biology·C LesieurF Gisou van der Goot
Nov 26, 2009·Critical Reviews in Biochemistry and Molecular Biology·Karen A Boehme, Christine Blattner
May 1, 2004·International Journal of Dermatology·Christina S SanderJens J Thiele
Sep 18, 2007·Journal of Neurochemistry·Roberto MaggioMarco Parenti
Apr 8, 2016·Cell Death & Disease·W RuanP A Barker
Nov 15, 2011·Systems Biology in Reproductive Medicine·Amy E SiebertVirinder K Moudgil
Mar 3, 2010·Annual Review of Biophysics·Kristen F SwaneyPeter N Devreotes
Feb 1, 2005·Trends in Microbiology·Laurence AbramiF Gisou van der Goot
Jul 1, 2009·Molecular Aspects of Medicine·R John Collier
Jan 8, 2013·Molecular Oncology·Andrew J McCluskeyR John Collier
Apr 6, 2000·The Journal of Biological Chemistry·H BarthK Aktories
Oct 3, 2001·Nature Biotechnology·M MourezR J Collier
Jul 22, 2004·Annals of the New York Academy of Sciences·Jeanette I WebsterEsther M Sternberg
Feb 27, 1997·Nature·C PetosaR C Liddington
Sep 27, 2005·The Journal of Biological Chemistry·Joshua T WolfeR John Collier
Mar 21, 2001·Biotechnology & Genetic Engineering Reviews·E S Hickman, K Helin
Jun 18, 2017·Annual Review of Microbiology·Dominique Missiakas, Olaf Schneewind
Nov 21, 2001·The Journal of Biological Chemistry·D Borden LacyR John Collier
Dec 13, 2000·The Journal of Biological Chemistry·B R SellmanR J Collier
Jul 4, 2008·Clinical and Vaccine Immunology : CVI·Sarah C Taft, Alison A Weiss
Jun 28, 2001·FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology·C BachmeyerM R Popoff
Apr 23, 2015·Bioorganicheskaia khimiia·A N Noskov
Jul 5, 2016·Toxins·Christopher Bachran, Stephen H Leppla
Aug 10, 2005·The Journal of Biological Chemistry·Kelly M HalversonJohn J Kasianowicz
Oct 8, 2019·Biophysical Journal·Sanaz Momben AbolfathEkaterina M Nestorovich
Jan 1, 1997·Life Sciences·G J MilczarekG T Bowden
Jun 7, 1996·Biochimica Et Biophysica Acta·T M Gottlieb, M Oren

❮ Previous
Next ❯

Related Concepts

Related Feeds

Anthrax Vaccines (ASM)

Three different types of anthrax vaccines are available; a live-attenuated, an alum-precipitated cell-free filtrate and a protein recombinant vaccine. The effectiveness between the three is uncertain, but the live-attenuated have shown to reduce the risk of anthrax with low adverse events. Here is the latest research on anthrax vaccines.

Anthrax Vaccines

Three different types of anthrax vaccines are available; a live-attenuated, an alum-precipitated cell-free filtrate and a protein recombinant vaccine. The effectiveness between the three is uncertain, but the live-attenuated have shown to reduce the risk of anthrax with low adverse events. Here is the latest research on anthrax vaccines.

ASBMB Publications

The American Society for Biochemistry and Molecular Biology (ASBMB) includes the Journal of Biological Chemistry, Molecular & Cellular Proteomics, and the Journal of Lipid Research. Discover the latest research from ASBMB here.